Mark Stockdale joins Solentim in new “Amalgamator of Business and Biology” position
Bournemouth, UK, 8th October 2019: Solentim, the global leader in cell line development instrumentation, is delighted to announce that Mark Stockdale is starting at Solentim in a brand-new role as Amalgamator of Business and Biology.
Mark has previously spent 10 years at Horizon Discovery, most recently working within the Applied Products Division as an R&D Manager for applications in bioprocessing. He led a team developing new mammalian host cell lines for the bioprocess industry and conducted strategic planning to deliver business growth and the deployment of technology in biopharma partner laboratories.
Mr Stockdale commented: “Solentim is thriving, having just reached its 10th year in business, it has built a strong track record of supporting the changing needs of the biopharma industry. I am delighted to support the team at Solentim, and their customers, by providing my guidance during this exciting next stage of growth.”
Aaron Figg, Managing Director at Solentim, commented: “Mark has almost 15 years’ experience in the biotechnology sector and is very well known and respected in the field of cell line development. He will be an extremely valuable asset to our team. We look forward to working with him to continue to develop and expand relationships at the highest level with our customers and to help identify new business opportunities.”